Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by JonEcashon Aug 29, 2017 2:01am
176 Views
Post# 26631020

Still here. Waiting.

Still here. Waiting.Been a while since I've posted, since there hasn't really been any reason to. Anyway, I'm still here holding all of my shares, as are others I'm sure. It was surprising and extremely frustrating to see the sp dip down as low as it did. I was one of those people who last year didn't believe we would ever be sub 25 again. But looking at the EOD house positions, it looks like someone (Anon) wanted out and had a lot of shares to sell. That in combinatoin with the summer doldrums and no major catalyst brings us to where we were. All I could do was pick up a few more shares and wait, and re-read their FS, MD&A and news releases. Everything looks exremely positive to me (plenty of cash so no need to finance, low float, receiving additional grants/funding, no negative reports about the technology, in talks with bigger pharma, plans ot jump to a senior exchange etc.) -it just takes so much investor patience to wait for biotech stocks to jump through the proper hoops and progress. Anyway it looks like the selling could be done as we're back up to 20 from 15 and the chart is looking so much stronger, so should get some technical momentum players to join us longs.

J$
Bullboard Posts